Evogene Ltd.

EVGNNASDAQHealthcare● Active

$0.58

$-0.04(-5.82%)

Market Cap$5023607

P/E Ratio—

52W High$2.42

52W Low$0.52

Avg Volume509K

Open$0.61

Beta0.74

Overview

Evogene Ltd. (EVGN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · EVGN · as of Mar 26, 2026

Latest filing snapshot

+16+114.29%vs prior year

Evogene Ltd. (EVGN) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

+16

Growth % (1Y)

+114.29%

Revenue / Employee

$128.4K

Net Income / Employee

$-282.8K

Market Cap

$5M

EVGN Employee Count

2013 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-26	2025-12-31	30	+16	+114.29%
2025-03-27	2024-12-31	14	-128	-90.14%
2024-03-28	2023-12-31	142	+5	+3.65%
2023-03-30	2022-12-31	137	-4	-2.84%
2022-03-31	2021-12-31	141	+10	+7.63%
2021-04-02	2020-12-31	131	-12	-8.39%
2020-04-27	2019-12-31	143	-7	-4.67%
2019-04-29	2018-12-31	150	-15	-9.09%
2018-03-30	2017-12-31	165	-20	-10.81%
2017-04-28	2016-12-31	185	-25	-11.90%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BOLT

Bolt Biotherapeutics, Inc.

DWTX

Dogwood Therapeutics, Inc.

12$3M

CLRB

Cellectar Biosciences, Inc.

11$8M #6

COCP

Cocrystal Pharma, Inc.

11$10M

AEON

AEON Biopharma, Inc.

5$9M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · EVGN peer comparison

About EVGN employees

EVGN Employees · Headcount

Evogene Ltd. (EVGN) employee data is sourced from the annual SEC 20-F filing. As of 2025, Evogene Ltd. had 30 full-time employees globally. Full-time employees only. Global consolidated headcount.

Evogene Ltd. employs 30 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $128,433, reflecting the company's operational efficiency.

Evogene Ltd.'s workforce increased by 16 (114.29%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Evogene Ltd.'s revenue per employee of $128,433 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

EVGN Employees · 5 questions

As of the latest SEC 20-F filing (2025), Evogene Ltd. had 30 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Evogene Ltd. employee counthow many employees does Evogene Ltd. haveEVGN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-26